News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
218 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (4450)
February (4428)
March (5683)
April (4545)
May (5703)
June (4805)
July (3912)
August (4762)
September (4260)
October (3860)
November (4837)
December (2683)
Day
1 (221)
2 (198)
3 (246)
4 (134)
5 (2)
6 (26)
7 (189)
8 (263)
9 (229)
10 (265)
11 (138)
12 (2)
13 (5)
14 (238)
15 (260)
16 (218)
17 (239)
18 (111)
19 (1)
20 (3)
21 (103)
22 (312)
23 (250)
24 (321)
25 (115)
26 (6)
27 (5)
28 (328)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
Business
Electromed, Inc., Appoints Christopher Holland Chief Commercial Officer
Electromed, Inc. today announced the appointment of Christopher Holland as Chief Commercial Officer.
February 16, 2022
·
4 min read
Policy
Jaguar Animal Health Seeks MUMS Designation from FDA for Canalevia (Crofelemer) for Treatment of Exercise-induced Diarrhea (EID) in Dogs
Jaguar Health, Inc. announced that it has submitted a request to the U.S. Food and Drug Administration’s Center for Veterinary Medicine for Minor Use/Minor Species designation for the company’s oral plant-based drug candidate Canalevia™ for treatment of exercise-induced diarrhea in dogs.
February 16, 2022
·
5 min read
Biotech Beach
Predicine to Present Six Studies, including the Demonstrating the Clinical Utility of Its PredicineBEACONTM, a Tissue-agnostic MRD Liquid Biopsy Solution, in Genitourinary (GU) Cancers at 2022 ASCO-GU Annual Conference
Predicine, a global molecular insights company, announced today that it will present six posters highlighting clinical utility of Predicine’s full suite of liquid- and tissue-based comprehensive genomic profiling solutions at the ASCO Genitourinary Cancers Symposium being held February 17-19, 2022, in San Francisco.
February 16, 2022
·
3 min read
Genetown
T2 Biosystems Announces Commercial Expansion Through Distributors in Norway, Finland and Türkiye
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced the execution of territory exclusive distribution agreements in Norway, Finland, and Türkiye.
February 16, 2022
·
4 min read
Biotech Beach
Acadia Pharmaceuticals Announces Resubmission of Supplemental New Drug Application to U.S. FDA for NUPLAZID® (pimavanserin) to Treat Alzheimer’s Disease Psychosis
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) announced today that it has resubmitted its supplemental New Drug Application (sNDA) for pimavanserin for the treatment of hallucinations and delusions associated with Alzheimer’s disease psychosis (ADP) to the U.S. Food and Drug Administration (FDA).
February 16, 2022
·
6 min read
Business
Farmacon Global Partners With Validcare for Performance-Based Clinical Research Solutions
“Validcare’s partnership with Farmacon Global will literally redefine clinical trial success from patient-centric design through database lock,” said Patrick McCarthy CEO Validcare.
February 16, 2022
·
2 min read
Marvel Biosciences Announces Proxy Tabulation and Shareholder Meeting Results
The Tabulation is the final sum of the voting results of the Meeting and is the result of all the properly submitted proxies by shareholders in advance of the proxy cut-off time.
February 16, 2022
·
6 min read
Business
ScreenPro Announces Changes to Board of Directors
Mr. Yeung has over 17 years of experience in capital markets, private equity, and investment banking, holding various roles from equity research, sales, and banking.
February 16, 2022
·
4 min read
Drug Development
Defence Retains CATO SMS to Advise on Its Phase I Clinical Trial on AccuTOX(TM) for Breast Cancer
CATO SMS is a consulting firm with more than 30 years of global experience to guide clinical development of biopharma pipelines.
February 16, 2022
·
3 min read
BioHarvest Sciences Inc. Trademarks Its Breakthrough Non-GMO Proven Platform Technology: “BIO-PLANT CELLicitation”
New name to reflect the Biotech power of combining plant cell growth with elicitation of specific molecules to produce unique compounds of high human utility value.
February 16, 2022
·
5 min read
Previous
3 of 22
Next